We found that TTF1-NP showed significantly inhibition on HepG2 cells and tumor growth in nude mice, as well as a significant inhibitory effect on the expressions of STAT3 and p-STAT3, which correlated with the treatment dose of TTF1-NP in HepG2 cells and nude mice with implanted HepG2 cells. This evidence concerns the gene TTF1 and neoplasm.